New Generation VMAT2 Inhibitors Induced Parkinsonism

Authors

Rani Priyanka Vasireddy, University of KentuckyFollow
Brent Sokola, University of KentuckyFollow
Zain Guduru, University of KentuckyFollow

Abstract

Highlights

• Drug induced parkinsonism caused by valbenazine and deutetrabenazine.
• Possible side effects of VMAT-2 inhibitors.
• Valbenazine and deutetrabenazine can unmask underlying Parkinson’s Disease.

Document Type

Article

Publication Date

11-7-2020

Notes/Citation Information

Published in Clinical Parkinsonism & Related Disorders, v. 3, 100078.

© 2020 The Author(s)

This is an open access article under the CC BY license (https://creativecommons.org/licenses/by/4.0/).

Digital Object Identifier (DOI)

https://doi.org/10.1016/j.prdoa.2020.100078

Repository Citation

Vasireddy, Rani Priyanka; Sokola, Brent; and Guduru, Zain, "New Generation VMAT2 Inhibitors Induced Parkinsonism" (2020). Neurology Faculty Publications. 58.
https://uknowledge.uky.edu/neurology_facpub/58